Abstract
The Ewing’s sarcoma family can present diagnostic difficulties. In the past the basis of diagnosis has been a exclusion. Identification of a specific translocation especially t(11; 22) (EWS-FLI 1 fusion gene), which is seen in nearly 85% of Ewing’s sarcoma cases can help in precise diagnosis. We have carried out a study on twenty patient samples diagnosed to have Ewing’s sarcoma/peripheral neuroectodermal tumour (PNET)/small round cell malignant tumour. The study involved RT-PCR analysis for the fusion transcript, followed by sequencing to identify the specific type of fusion. Ninety percent (18/20) of the samples tested were found to be t(11; 22) translocations involving EWS-FLI 1 genes. Sixty-one percent (11/18) were found to be type 1 fusion and seven were type 2 (39%). This is the first study in India with quantitative information about the types of EWS-FLI 1 translocations present in Ewing’s family of tumours in south Indian patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aurias A, Rimbaut C, Buffe D, Dubousset J and Mazarabad A1983 Chromosomal translocations in Ewing’s sacoma;N. Engl. J. Med. 309 496–497
Barr F G, Qualman S J, Macris M H, Melnick N, Lawler E R, Strzelecki D M, Triche T J, Bridge J A and Sorenson P H 2002 Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusion;Cancer Res. 62 4704–4710
de Alava Eand Gerald W L J 2000 Molecular biology of Ewing’ s sarcoma/primitive neuroectodermal tumor family;Clin. Oncol. 18 204–213
de Alava E, Kawai A, Healey J H, Fligman I, Meyers P A, Huvos A G, Gerald W L, Jhanwar S C, Argani P, Antonescu C R, Pardo-Mindass F J, Ginsberg J, Womer R, Lawlor E R, Wunder J, Andrulis I, Sorensen P H, Barr F G and Ladyani M 1998 EWS-FLI 1 fusion transcript is an independent determinant of prognosis in Ewing’s sarcoma;J. Clin. Oncol. 16 1248–1255
Delattre O, Zucman J, Melot T, Garau X S, Zucker J-M, Lenoir G M, Ambross P F, Sheer D, Turc-Carel C, Triche T J, Aurias A and Thomas G 1994 The Ewing family of tumors — a subgroup of small-round-cell tumors defined by specific chimeric transcripts;New. Engl. J. Med. 331 294–299
Dowing J R, Head D R, Parham D M, Dougalss E C, Hulshof M G, Link M P, Motroni T A, Grier H E and Shapiro D N 1993 Detection of the (11; 22)(q 24; q 12) translocation of Ewing’s’ sarcoma peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction;Am. J. Pathol. 143 1294–1300
Granter S R, Renshaw A A, Fletcher C D, Bhan A K and Rosenberg A E 1996 CD 99 reactivity in mesenchymal chondrosarcoma;Hum. Pathol. 27 1273–1276
Katz R I, Quezado M, Senderowicz A M, Villalba L, Laskin W B and Tsokos M 1997 An intra-abdominal small round cell neoplasm with features of primitive neuroectodermal and desmoplastic round cell tumor and a EWS/FLI-1 fusion transcript;Hum. Pathol. 28 502–509
Levy E R and Herrington C S 1995Non-isotopic methods in molecular biology — A practical approach (IRL Press)
Ladanyi M and Gerald W 1994 Fusion of the EWS and WT1 genes in Desmoplastic small round cell tumor;Cancer Res. 54 2837–2840
McNicol A M and Farquharson M A 1997 In situ hybridization and its diagnostic application in Pathology;J. Pathol. 182 250–261
Naito N, Kawai A, Ouchida M, Dan’ura T, Morimoto Y, Ozaki T, Shimizu K and Inoue H 2000 A reverse transcriptase-polymerase reaction assay in the diagnosis of soft tissue sarcomas;Cancer 89 1992–1998
Peter M, Magdelenet H, Michon J, Melot T, Oberlin O, Zucker J M, Thomas G and Delattre O 1995 Sensitive detection of occult Ewing’s’ cells by reverse transcriptase-polymerase chain reaction;Br. J. Cancer 72 96–100
Pfleiderer C, Zoubek A, Gruber B, Kronberger M, Ambros P F, Lion T, Gander H and Kovari H 1995 Detection of tumor cells in peripheral blood and bone marrow from Ewing’s tumor patients by RT-PCR;Int. J. Cancer 64 135–139
Sorensen P H, Lessnick S L, Lopez-T D, Liu X F, Triche T J and Denny C T 1994 A second Ewing’s sarcoma translocation, t(21, 22) fuses the EWS gene to another ETS family transcription factor, ERG;Nature Genet. 6 146–151
Stevenson A J, Chatten J, Bertoni F and Miettinen M1994 CD 99 (p30/32 MIC 2) neuroectodermal/Ewing’s’ sarcoma antigen as an IHC marker. Review of more than 600 tumors and the literature experience;Appl. Immunohistochem. 2 231–240
Vijayalakshmi N, Selvaluxmi G, Majhi U and Rajkumar T 2002 c-myc oncoprotein expression and prognosis in patients with carcinoma cervix — An immunohistochemical study;Eur. J. Gynaecol. Oncol. 23 135–138
Zoubek A, Dockhorn-Dworniczak B, Delattre O, Christansen H, Niggli F, Gatterer-Menz I, Smith T L, Jurgens H, Gadner H and Kovar H 1996 Expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumour patients?;J. Clin. Oncol. 14 1245–1251
Zucman J, Melot T, Desmaze C, Ghysdael J, Plougastel B, Peter M, Zucker J M, Triche T J, Sheer D and Turc-Carel C 1993 Combinatorial generation of variable fusion proteins in the Ewing’s’ family of tumors;EMBO J. 12 4481–4487
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Parija, T., Shirley, S., Uma, S. et al. Type 1 (11; 22)(q24: q12) translocation is common in Ewing’s sarcoma/ peripheral neuroectodermal tumour in south Indian patients. J. Biosci. 30, 371–376 (2005). https://doi.org/10.1007/BF02703674
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02703674